DSM-Firmenich reported 6% organic sales growth in the second quarter on Thursday, July 30, exceeding analysts’ expectations. Organic growth reached 5% in the first half of the year, supported by double-digit growth in its perfumes business, across both the Fine Fragrances and Consumer Fragrances segments, while the beauty Ingredients segment was stable.
DSM-Firmenich posted revenue of EUR 2.388 billion in the second quarter, taking first-half revenue to EUR 4.664 billion. The group reaffirmed its 2026 organic sales growth guidance of 2-4%.
In the second quarter, the Perfumery & Beauty division posted organic sales growth of 7%, with revenue of EUR 981 million. The Taste, Texture & Health division recorded organic sales growth of 6% — well above analysts’ estimates — with revenue of EUR 843 million. Finally, the Health, Nutrition & Care division achieved organic sales growth of 4%, with revenue of EUR 538 million.
“We achieved good volume-led LFL growth in the first six months of the year across all businesses, demonstrating the resilience and quality of our portfolio and the consistent delivery on our operational priorities amid a dynamic global macroeconomic environment," commented DSM-Firmenich CEO Dimitri de Vreeze.
